BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Prognosis
130 results:

  • 1. TSPAN6 reinforces the malignant progression of glioblastoma via interacting with CDK5RAP3 and regulating stat3 signaling pathway.
    Zhang C; Du FH; Wang RX; Han WB; Lv X; Zeng LH; Chen GQ
    Int J Biol Sci; 2024; 20(7):2440-2453. PubMed ID: 38725860
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. KIAA0040 enhances glioma growth by controlling the JAK2/stat3 signalling pathway.
    He J; Xue K; Fan F; Li L; Rao X; Liu W; Nie C
    J Cell Mol Med; 2024 Apr; 28(8):e18332. PubMed ID: 38661644
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The FKBP51s Splice Isoform Predicts Unfavorable prognosis in Patients with Glioblastoma.
    Giordano C; Marrone L; Romano S; Della Pepa GM; Donzelli CM; Tufano M; Capasso M; Lasorsa VA; Quintavalle C; Guerri G; Martucci M; Auricchio A; Gessi M; Sala E; Olivi A; Romano MF; Gaudino S
    Cancer Res Commun; 2024 May; 4(5):1296-1306. PubMed ID: 38651817
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nuclear autoantigenic sperm protein facilitates glioblastoma progression and radioresistance by regulating the ANXA2/stat3 axis.
    Qiu Y; Pei D; Wang M; Wang Q; Duan W; Wang L; Liu K; Guo Y; Luo L; Guo Z; Guan F; Wang Z; Xing A; Liu Z; Ma Z; Jiang G; Yan D; Liu X; Zhang Z; Wang W
    CNS Neurosci Ther; 2024 Apr; 30(4):e14709. PubMed ID: 38605477
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. stat3 phosphorylation inhibitor Bt354 exhibits anti-neoplastic activity in glioblastoma multiforme cells.
    Chiang YC; Selvam P; Liu YX; Shih PC; Chen NF; Kuo HM; Lin HY; Wen ZH; Chen WF
    Environ Toxicol; 2024 Jun; 39(6):3292-3303. PubMed ID: 38415901
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ITGA2 as a prognostic factor of glioma promotes GSCs invasion and EMT by activating stat3 phosphorylation.
    Zhang J; Li R; Zhang H; Wang S; Zhao Y
    Carcinogenesis; 2024 Apr; 45(4):235-246. PubMed ID: 38142122
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Driver gene KRAS aggravates cancer-associated stroke outcomes.
    Yan H; Sasaki T; Gon Y; Nishiyama K; Kanki H; Mochizuki H
    Thromb Res; 2024 Jan; 233():55-68. PubMed ID: 38029547
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating stat3 in glioblastoma.
    Chen Y; Mu Y; Guan Q; Li C; Zhang Y; Xu Y; Zhou C; Guo Y; Ma Y; Zhao M; Ji G; Liu P; Sun D; Sun H; Wu N; Jin Y
    Cell Death Dis; 2023 Nov; 14(11):757. PubMed ID: 37985768
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.
    Shin JE; Kim SH; Kong M; Kim HR; Yoon S; Kee KM; Kim JA; Kim DH; Park SY; Park JH; Kim H; No KT; Lee HW; Gee HY; Hong S; Guan KL; Roe JS; Lee H; Kim DW; Park HW
    Mol Cancer; 2023 Nov; 22(1):177. PubMed ID: 37932786
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma.
    Pang F; Zhang L; Li M; Yi X; Wang Y; Yang P; Wen B; Jiang J; Teng Y; Yang X; Chen L; Xu J; Wang L
    Cancer Gene Ther; 2023 Dec; 30(12):1636-1648. PubMed ID: 37726387
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Tumor-associated astrocytes promote tumor progression of Sonic Hedgehog medulloblastoma by secreting lipocalin-2.
    Li H; Liu Y; Liu Y; Xu L; Sun Z; Zheng D; Liu X; Song C; Zhang Y; Liang H; Yang B; Tian X; Luo J; Chang Q
    Brain Pathol; 2024 Jan; 34(1):e13212. PubMed ID: 37721122
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma.
    Pang L; Dunterman M; Guo S; Khan F; Liu Y; Taefi E; Bahrami A; Geula C; Hsu WH; Horbinski C; James CD; Chen P
    Nat Immunol; 2023 Oct; 24(10):1654-1670. PubMed ID: 37667051
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Targeting EZH2 regulates the biological characteristics of glioma stem cells via the Notch1 pathway.
    Zhao G; Deng Z; Li X; Wang H; Chen G; Feng M; Zhou Y
    Exp Brain Res; 2023 Oct; 241(10):2409-2418. PubMed ID: 37644332
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program.
    Park J; Shim JK; Lee M; Kim D; Yoon SJ; Moon JH; Kim EH; Park JY; Chang JH; Kang SG
    Br J Cancer; 2023 Oct; 129(7):1061-1070. PubMed ID: 37558923
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. HOXD-AS2-stat3 feedback loop attenuates sensitivity to temozolomide in glioblastoma.
    Zhang ZX; Ren P; Cao YY; Wang TT; Huang GH; Li Y; Zhou S; Yang W; Yang L; Liu GL; Xiang Y; Pei YC; Chen QZ; Chen JX; Lv SQ
    CNS Neurosci Ther; 2023 Nov; 29(11):3430-3445. PubMed ID: 37308741
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. ZDHHC15 promotes glioma malignancy and acts as a novel prognostic biomarker for patients with glioma.
    Liu ZY; Lan T; Tang F; He YZ; Liu JS; Yang JZ; Chen X; Wang ZF; Li ZQ
    BMC Cancer; 2023 May; 23(1):420. PubMed ID: 37161425
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Flubendazole exhibits anti-glioblastoma effect by inhibiting stat3 and promoting cell cycle arrest.
    Vítovcová B; Skarková V; Havelek R; Soukup J; Pande A; Caltová K; Rudolf E
    Sci Rep; 2023 Apr; 13(1):5993. PubMed ID: 37045903
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. IGFBP2 promotes proliferation and cell migration through stat3 signaling in Sonic hedgehog medulloblastoma.
    Kunhiraman H; McSwain L; Shahab SW; Gershon TR; MacDonald TJ; Kenney AM
    Acta Neuropathol Commun; 2023 Apr; 11(1):62. PubMed ID: 37029430
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. MEK5-ERK5 Axis Promotes Self-renewal and Tumorigenicity of Glioma Stem Cells.
    Fukasawa K; Lyu J; Kubo T; Tanaka Y; Suzuki A; Horie T; Tomizawa A; Osumi R; Iwahashi S; Tokumura K; Murata M; Kobayashi M; Todo T; Hirao A; Hinoi E
    Cancer Res Commun; 2023 Jan; 3(1):148-159. PubMed ID: 36968222
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Radiotherapy opens the blood-brain barrier and synergizes with anlotinib in treating glioblastoma.
    Li PJ; Lai SZ; Jin T; Ying HJ; Chen YM; Zhang P; Hang QQ; Deng H; Wang L; Feng JG; Chen XZ; Guo P; Chen M; Tian Y; Chen YY
    Radiother Oncol; 2023 Jun; 183():109633. PubMed ID: 36963438
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.